On January 9, 2026, iFlytek Medical Technology (02506.HK) saw a strong rebound in its stock price on the Hong Kong Stock Exchange. The company's stock closed at HKD 98.00, up 21.14% from the opening price of HKD 84.40. The stock price once surged over 20%, driven by the company's ongoing innovation in the AI healthcare sector. Looking at the intraday chart, the stock maintained a narrow range in the morning, with its upward momentum accelerating in the afternoon, signaling growing market attention towards the company.

(Image source: uSMART HK app)
As a company focused on AI applications in the healthcare field, iFlytek Medical Technology has long been advancing its technology and product offerings in areas such as large medical models, assistive diagnostic systems, intelligent medical records, and grassroots healthcare information systems. With the continuous maturity of large model technology, the application boundaries of AI in medical scenarios are expanding, leading to growing interest in how it can improve diagnostic efficiency and optimize the allocation of medical resources.
In recent years, as demand for medical digitalization and intelligence continues to rise, companies with algorithm capabilities and medical data accumulation are increasingly gaining an advantage. The company’s product deployment in real-world medical settings and collaborations with healthcare institutions have become key points of focus for the market.
From an industry perspective, healthcare is widely regarded as one of the most specialized, accurate, and compliance-demanding sectors for large model applications. Compared to general scenarios, AI in healthcare places greater emphasis on long-term data accumulation, clinical validation, and a stable application environment. This makes companies with technical expertise and industry resources more likely to establish barriers to entry.
Recently, international tech companies’ involvement in the healthcare sector has drawn further market attention. Public information reveals that OpenAI has launched the ChatGPT Health feature, focusing on health issue resolutions, smart device data integration, and lifestyle management, further expanding the boundaries of generative AI in healthcare. Industry experts believe that the ongoing investments by leading global tech firms help validate the feasibility of large models in healthcare settings and raise market awareness of the long-term potential for AI in healthcare.Public data shows that iFlytek Medical Technology continues to advance product deployment in specific healthcare scenarios, such as assistive diagnostics, intelligent medical record quality control, and grassroots healthcare information systems. As these systems see more frequent use in real healthcare processes, the industry’s focus is shifting towards the evolution of AI in healthcare from being a "tool" to a "system capability."
Overall, the activity in the Hong Kong technology sector has recently increased, with AI healthcare as one of the key applications of artificial intelligence continuing to attract market attention. Progress in areas such as technology iteration, scenario deployment, and business model exploration has become an important reference for investors evaluating the development potential of relevant companies.
With the joint forces of policy support, technological advancement, and growing healthcare demands, the future direction of the AI healthcare sector will continue to be one of the main focuses for the market.
After logging into the uSMART HK app, click the “Search” button in the top-right corner of the page, enter the ticker code (02506.HK), and navigate to the details page to view transaction details and historical trends. Click the “Trade” button in the bottom-right corner, select the trade type, and submit your order after filling in the transaction conditions.

(Image Source: uSMART HK app)
